Neurocognitive Mechanisms of Sentence Production Impairment in Aphasia
University of Maryland, College Park · with McMaster University · NCT06405594
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 350
- US sites recruiting
- 1
- Study start
- August 1, 2024
- Record last updated
- September 3, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The proposed research is relevant to public health because stroke is a leading cause of long-term disability among older adults and communication impairments resulting from stroke have a significant negative impact on quality of life. By seeking to better understand post-stroke aphasia, this project lays the groundwork for development of new interventions, and aligns with NIDCD's priority areas 1 (understanding normal function), 2 (understanding diseases), and 3 (improving diagnosis, treatment, and prevention).
Being studied: Language Condition
Conditions: Aphasia, Acquired; Stroke; Healthy Aging
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- At least 18 years of age
- Persons with acquired aphasia are defined as those with a language impairment following left hemisphere brain injury (most likely a stroke).
- Neurotypical adults need to be either young (ages 18-30 years) or older (> 60 years)
- Native (or primary) speakers of English
Exclusion Criteria
- Prior neurological or psychiatric diagnoses or developmental disabilities before the onset of aphasia
- do not speak English fluently
Recruiting US locations
University of Maryland
College Park, MD 20742
Site contact: Yasmeen Faroqi-Shah, PhD · 301-405-4229 · yfshah@umd.edu
Study contacts (from the official record)
- Yasmeen Faroqi-Shah, PhD · 3014054229 · yfshah@umd.edu
- Robert Slevc, PhD · (301) 405-5835 · slevc@umd.edu
Similar studies in Maryland
All neurology studies in Maryland →- RecruitingHealthy volunteersPhase 1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Suninflam Inc
- Location
- Bathesda, MD + 9 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
First-in-Human Single and Multiple Dose of HL-400
Highlightll Pharmaceutical (USA) LLC
- Location
- Baltimore, MD
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis
PRG Science & Technology Co., Ltd.
- Location
- Baltimore, MD
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
National Institute of Mental Health (NIMH)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 50–100